Back to User profile » Prof. Dr. Giovanni Scambia
Papers published by Prof. Dr. Giovanni Scambia:
Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?
Boccia SM, Sassu CM, Ergasti R, Vertechy L, Apostol AI, Palluzzi E, Fagotti A, Scambia G, Marchetti C
Drug Design, Development and Therapy 2024, 18:2021-2032
Published Date: 7 June 2024
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data
Agostinelli V, Musacchio L, Camarda F, Salutari V, Carbone MV, Ghizzoni V, Nero C, Ricci C, Perri MT, Giudice E, Lardino S, Berardi R, Scambia G, Lorusso D
Cancer Management and Research 2023, 15:1063-1072
Published Date: 27 September 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long-term efficacy and safety of human papillomavirus vaccination
De Vincenzo R, Conte C, Ricci C, Scambia G, Capelli G
International Journal of Women's Health 2014, 6:999-1010
Published Date: 3 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G
OncoTargets and Therapy 2014, 7:1273-1284
Published Date: 12 July 2014